Skip to main content
Erschienen in: Pediatric Nephrology 6/2022

03.11.2021 | Original Article

An initiative to improve pneumococcal immunization counseling in children with nephrotic syndrome

verfasst von: Ibrahim Sandokji, Linda S. Anderson, Jillian K. Warejko, Beth L. Emerson, Jason H. Greenberg

Erschienen in: Pediatric Nephrology | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Immunization is essential in preventing life-threatening pneumococcal infections in children with nephrotic syndrome. An additional 23-valent pneumococcal polysaccharide vaccine (PPSV23) series is required for children with nephrotic syndrome. Despite current practice guidelines, many children with nephrotic syndrome do not receive PPSV23.

Methods

Our nephrology clinic conducted a quality improvement project to improve the overall rate of PPSV23 counseling to more than 70% within a 12-month period by applying several targeted interventions to raise providers’ awareness, improve communication with primary care providers, and increase provider adherence. Data was collected from the electronic health record (EHR), and monthly performance was tracked via monthly control charts and overall immunization counseling rate charts.

Results

We increased adherence to PPSV23 vaccination counseling from a baseline of 12 to 86%. The first intervention that effectively increased the vaccine counseling rate from 12 to 30% was improving a provider’s awareness of the PPSV23 literature and vaccine guidelines. Other interventions included regular performance reviews at division meetings, creating an immunization protocol, posting performance charts on the office bulletin board, and unifying vaccine recommendation templates. Lastly, specific and timely EHR reminders improved the total counseling rate from 52 to 86% and maintained adherence until the completion of the project.

Conclusion

Bridging the knowledge gap in provider awareness and using specific EHR reminders can improve adherence to PPSV23 counseling in children with nephrotic syndrome. Such interventions could be applied to similar groups of immunocompromised patients in whom additional vaccines are indicated.

Graphical abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Goonewardene ST, Tang C, Tan LT, Chan KG, Lingham P, Lee LH, Goh BH, Pusparajah P (2019) Safety and efficacy of pneumococcal vaccination in pediatric nephrotic syndrome. Front Pediatr 7:339CrossRef Goonewardene ST, Tang C, Tan LT, Chan KG, Lingham P, Lee LH, Goh BH, Pusparajah P (2019) Safety and efficacy of pneumococcal vaccination in pediatric nephrotic syndrome. Front Pediatr 7:339CrossRef
2.
Zurück zum Zitat Uncu N, Bulbul M, Yildiz N, Noyan A, Kosan C, Kavukcu S, Caliskan S, Gunduz Z, Besbas N, Gur Guven A (2010) Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study. Eur J Pediatr 169:73–76CrossRef Uncu N, Bulbul M, Yildiz N, Noyan A, Kosan C, Kavukcu S, Caliskan S, Gunduz Z, Besbas N, Gur Guven A (2010) Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study. Eur J Pediatr 169:73–76CrossRef
3.
Zurück zum Zitat Vandecasteele SJ, Ombelet S, Blumental S, Peetermans WE (2015) The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. Clin Kidney J 8:318–324CrossRef Vandecasteele SJ, Ombelet S, Blumental S, Peetermans WE (2015) The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. Clin Kidney J 8:318–324CrossRef
5.
Zurück zum Zitat Nuorti JP, Whitney CG (2010) Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59:1–18PubMed Nuorti JP, Whitney CG (2010) Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59:1–18PubMed
6.
Zurück zum Zitat Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI (2014) Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine 32:1394–1397CrossRef Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI (2014) Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine 32:1394–1397CrossRef
7.
Zurück zum Zitat Pittet LF, Posfay-Barbe KM, Chehade H, Rudin C, Wilhelm-Bals A, Rodriguez M, Siegrist CA, Parvex P (2016) Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine. Vaccine 34:4948–4954CrossRef Pittet LF, Posfay-Barbe KM, Chehade H, Rudin C, Wilhelm-Bals A, Rodriguez M, Siegrist CA, Parvex P (2016) Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine. Vaccine 34:4948–4954CrossRef
8.
Zurück zum Zitat Cattran DC, Feehally J, Cook HT, Liu ZH, Fervenza F, Mezzano S, Floege J, Nachman PH, Gipson DS, Praga M, Glassock R, Radhakrishnan J, Hodson E, Rovin B, Jha V, Troyanov S, Li PKT, Wetzels J (2012) Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney International Supplements 2:139–274 Cattran DC, Feehally J, Cook HT, Liu ZH, Fervenza F, Mezzano S, Floege J, Nachman PH, Gipson DS, Praga M, Glassock R, Radhakrishnan J, Hodson E, Rovin B, Jha V, Troyanov S, Li PKT, Wetzels J (2012) Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney International Supplements 2:139–274
9.
Zurück zum Zitat Tran CL, Selewski DT, Oh GJ, Troost JP, Massengill SF, Al-Akash SI, Mahesh S, Amin R, Ashoor IF, Chanchlani R, Kallash M, Woroniecki RP, Gipson DS (2021) Pediatric immunization practices in nephrotic syndrome: an assessment of provider and parental knowledge. Front Pediatr 8:619548CrossRef Tran CL, Selewski DT, Oh GJ, Troost JP, Massengill SF, Al-Akash SI, Mahesh S, Amin R, Ashoor IF, Chanchlani R, Kallash M, Woroniecki RP, Gipson DS (2021) Pediatric immunization practices in nephrotic syndrome: an assessment of provider and parental knowledge. Front Pediatr 8:619548CrossRef
11.
Zurück zum Zitat Gaudreault-Tremblay MM, McQuillan RF, Parekh RS, Noone D (2020) Quality improvement in pediatric nephrology-a practical guide. Pediatr Nephrol 35:199–211CrossRef Gaudreault-Tremblay MM, McQuillan RF, Parekh RS, Noone D (2020) Quality improvement in pediatric nephrology-a practical guide. Pediatr Nephrol 35:199–211CrossRef
13.
14.
Zurück zum Zitat Kenett RS, Baker E (1999) Software process quality: management and control. CRC Press, Boca RatonCrossRef Kenett RS, Baker E (1999) Software process quality: management and control. CRC Press, Boca RatonCrossRef
15.
Zurück zum Zitat Perla RJ, Provost LP, Murray SK (2011) The run chart: a simple analytical tool for learning from variation in healthcare processes. BMJ Qual Saf 20:46–51CrossRef Perla RJ, Provost LP, Murray SK (2011) The run chart: a simple analytical tool for learning from variation in healthcare processes. BMJ Qual Saf 20:46–51CrossRef
16.
Zurück zum Zitat Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D (2016) SQUIRE 2.0 (standards for quality improvement reporting excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf 25:986–992CrossRef Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D (2016) SQUIRE 2.0 (standards for quality improvement reporting excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf 25:986–992CrossRef
17.
Zurück zum Zitat Malone K, Clark S, Palmer JA, Lopez S, Pradhan M, Furth S, Kim J, Fisher B, Laskin B (2016) A quality improvement initiative to increase pneumococcal vaccination coverage among children after kidney transplant. Pediatr Transplant 20:783–789CrossRef Malone K, Clark S, Palmer JA, Lopez S, Pradhan M, Furth S, Kim J, Fisher B, Laskin B (2016) A quality improvement initiative to increase pneumococcal vaccination coverage among children after kidney transplant. Pediatr Transplant 20:783–789CrossRef
18.
Zurück zum Zitat Harris JG, Maletta KI, Ren B, Olson JC (2015) Improving pneumococcal vaccination in pediatric rheumatology patients. Pediatrics 136:e681-686CrossRef Harris JG, Maletta KI, Ren B, Olson JC (2015) Improving pneumococcal vaccination in pediatric rheumatology patients. Pediatrics 136:e681-686CrossRef
19.
Zurück zum Zitat Sivaraman V, Wise KA, Cotton W, Barbar-Smiley F, Al Ahmed O, MacDonald D, Lemle S, Yildirim-Toruner C, Ardoin SP, Ardura MI (2020) Previsit planning improves pneumococcal vaccination rates in childhood-onset SLE. Pediatrics 145:e20183141CrossRef Sivaraman V, Wise KA, Cotton W, Barbar-Smiley F, Al Ahmed O, MacDonald D, Lemle S, Yildirim-Toruner C, Ardoin SP, Ardura MI (2020) Previsit planning improves pneumococcal vaccination rates in childhood-onset SLE. Pediatrics 145:e20183141CrossRef
20.
Zurück zum Zitat Scheuerman O, Zilber E, Davidovits M, Chodick G, Levy I (2017) Nephrologists need to play a key role in improving annual influenza vaccination rates in children with kidney disease. Acta Paediatr 106:812–818CrossRef Scheuerman O, Zilber E, Davidovits M, Chodick G, Levy I (2017) Nephrologists need to play a key role in improving annual influenza vaccination rates in children with kidney disease. Acta Paediatr 106:812–818CrossRef
Metadaten
Titel
An initiative to improve pneumococcal immunization counseling in children with nephrotic syndrome
verfasst von
Ibrahim Sandokji
Linda S. Anderson
Jillian K. Warejko
Beth L. Emerson
Jason H. Greenberg
Publikationsdatum
03.11.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 6/2022
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-021-05305-3

Weitere Artikel der Ausgabe 6/2022

Pediatric Nephrology 6/2022 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.